• Return to Headlines

Juno Therapeutic Shares Up 78.2% Since SmarTrend's Buy Recommendation (JUNO)

By James Quinn

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 11 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96.

Over the past year, Juno Therapeutic has traded in a range of $42.29 to $87.01 and is now at $86.96, 106% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Juno Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services. Juno Therapeutics serves the healthcare sector in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Juno Therapeutic shares.

Log in and add Juno Therapeutic (JUNO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights juno therapeutic

Ticker(s): JUNO